Small Intestinal Bacterial Overgrowth versus Antimicrobial Capacity in Patients with Spontaneous Bacterial Peritonitis

References

• Toledo C, Salmeron JM, Rimola A, Navasa M, Arroyo V, Llach J, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251–7.
   PubMed Web of Science ®Google Scholar
• Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention. Am J Med 1994;97:169–75.
   Google Scholar
• Boixeda D, De Luis DA, Aller R, De Argila CM. Spontaneous bacterial peritonitis: clinical and microbiological study of 233 episodes. J Clin Gastroenterol 1996;23:275–9.
   PubMedGoogle Scholar
• Chu CM, Chang KY, Liaw YF. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci 1995;40:561–5.
   Google Scholar
• Wang SS, Tsai YT, Lee SD, Chen HT, Lu CW, Lee FY, et al. Spontaneous bacterial peritonitis in patients with hepatitis B-related cirrhosis and hepatocellular carcinoma. Gastroenterology 1991;101:1656–62.
   PubMedGoogle Scholar
• Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984;4:53–8.
   PubMed Web of Science ®Google Scholar
• Hassner A, Kletter Y, Shlag D, Yedvab M, Aronson M, Shibolet S, et al. Impaired monocyte function in liver cirrhosis. Br Med J Clin Res Ed 1981;282:1262–3.
   PubMedGoogle Scholar
• Oliveir K, Colette L, Andre PP. Complement and liver cell function in 53 patients with liver disease. Am J Med 1973;55: 783–90.
   Google Scholar
• Morencos FC, Castana GDLH, Ramos LM, Arias MJL, Ledesma F, Romero FP. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995;40:1252–6.
   PubMed Web of Science ®Google Scholar
• Allgayer H, Pham HQ. Can H2-breath tests predict endotoxemia, infection or survival in alcoholic liver cirrhosis? Gastroenterology 1992;102:A773.
   Google Scholar
• Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebocontrolled trial. Hepatology 1990;12:716–24.
   PubMed Web of Science ®Google Scholar
• Pugh RWH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984;4: 1209–11.
   PubMed Web of Science ®Google Scholar
• Sherman PM. Bacterial overgrowth. In: Yamada T, editor. Textbook of gastroenterology. Philadelphia: JB Lippincott; 1991. p. 1520–40.
   Google Scholar
• Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988;95: 982–8.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Tson CT, Kao CH, Lin WY, Hsu CY. Phagocytosis of the reticuloendothelial system in diabetes mellitus. Kaohsiung J Med Sci 1992;8:471–6.
   PubMedGoogle Scholar
• Wang SJ, Lan JL, Chang CP, Hsu CY, Lin WY, Kao CH. Phagocytosis of the reticuloendothelial system in systemic lupus erythematosus. Ann Nucl Med Sci 1993;6:97–101.
   Google Scholar
• Wyke RJ. Problems of bacterial infection in patients with liver disease. Gut 1987;28:623–41.
   PubMed Web of Science ®Google Scholar
• Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H₂ or CH4 breath tests. Scand J Gastroenterol 1998; 33:867–71.
   Google Scholar
• Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998;28:1187–90.
   PubMed Web of Science ®Google Scholar
• Horowitz M. Phagocytosis of microorganisms. Rev Infect Dis 1982;4:104–23.
   PubMedGoogle Scholar
• Agnello V. Complement deficiency states. Medicine 1978;57:1–23.
   PubMed Web of Science ®Google Scholar
• Potter BJ, Trueman AM, Jones EA. Serum complement in chronic liver disease. Gut 1973;14:451–6.
   Google Scholar
• Ellison III RT, Horsburgh R, Jr, Curd J. Complement levels in patients with hepatic dysfunction. Dig Dis Sci 1990;35:231–5.
   PubMedGoogle Scholar
• Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988;8:632–5.
   PubMed Web of Science ®Google Scholar
• Andreu M, Sola R, Stiges-Serra A, Alia C, Gallen M, Vila MC, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993;104: 1133–8.
   Google Scholar
• Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991;100:477–81.
   PubMed Web of Science ®Google Scholar
• Munoz LE, De Villiers D, Markham D, Whaley K, Thomas HC. Complement activation in chronic liver disease. Clin Exp Immunol 1982;47:548–54.
   PubMed Web of Science ®Google Scholar
• Gluud C, Jans H. Circulating immune complexes and complement concentrations in patients with alcoholic liver disease. J Clin Pathol 1982;35:380–4.
   PubMedGoogle Scholar
• Colten HR, Alper CA, Rosen FS. Current concepts in immunology: genetics and biosynthesis of complement proteins. N Engl J Med 1981;304:653–6.
   Google Scholar
• Homann C, Varming K, Hogasen K, Mollnes TE, Graudal N, Thomsen AC, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997;40:544–9.
   PubMed Web of Science ®Google Scholar
• Such J, Guarner C, Soriano G, Teixido M, Barrios J, Tena F, et al. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis. Hepatology 1990;12:1175–8.
   PubMedGoogle Scholar
• Riordan SM, McIver CJ, Wakefield D, Andreopoulos PC, Dancombe VM, Bolin TD, et al. Local and systemic complement activity in small intestinal bacterial overgrowth. Dig Dis Sci 1997;42:1128–36.
   PubMedGoogle Scholar
• Kelly PM, Heryet AR, McGee JO, McGree J. Kupffer cell number is normal, but their lysozyme content is reduced in alcoholic liver disease. J Hepatol 189;8:173–80.
   Google Scholar
• Rogers DE. Host mechanisms which act to remove bacteria from the blood stream. Bact Rev 1960;24:50–66.
   PubMedGoogle Scholar
• van Vlieet ACM, Bakker WH, Lindemans J, Wilson JHP, Zanten RAA. Plasma lysozyme level and reticuloendothelial system function in human liver disease. Clin Chem Acta 1981; 113:193–9.
   Google Scholar
• Cooksley WGE, Powell LW, Halliday JW. Reticuloendothelial phagocytic function in human liver disease and its relationship to liver haemolysis. Br J Haematol 1973;25:147–64.
   Google Scholar
• Lanhnborg G, Friman L, Berghem L. Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 1981;16:411–6.
   Google Scholar
• Wardle N, Anderson A, James O. Kupffer cell phagocytosis in relation to BSP clearance in liver and inflammatory bowel diseases. Dig Dis Sci 1980;25:414–9.
   Google Scholar
• Drivas G, James O, Wardle N. Study of the reticuloendothelial phagocytic capacity in patients with cholestasis. Br Med J 1976;1:1568–9.
   Google Scholar
• Bolognesi M, Merkel C, Blanco S, Angeli P, Sacerdoti D, Amodio P, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 1994;19:628–34.
   PubMedGoogle Scholar
• Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila C, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotic with low ascitic fluid protein levels. Gastroenterology 1999;117:414–9.
   PubMed Web of Science ®Google Scholar